United States Pyelonephritis Drug Market Report 2017

December 2017 | 97 pages | ID: U75E8564E7BEN
QYResearch

Abstracts

In this report, the United States Pyelonephritis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pyelonephritis Drug in these regions, from 2012 to 2022 (forecast).

United States Pyelonephritis Drug market competition by top manufacturers/players, with Pyelonephritis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Achaogen Inc
• AstraZeneca Plc
• Meiji Seika Pharma Co Ltd
• Merck & Co Inc
• MerLion Pharmaceuticals Pte Ltd
• The Medicines Company
• Zavante Therapeutics Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Finafloxacin
• Fosfomycin Tromethamine
• Nacubactam
• Plazomicin Sulfate
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pyelonephritis Drug Market Report 2017

1 PYELONEPHRITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Pyelonephritis Drug
1.2 Classification of Pyelonephritis Drug by Product Category
  1.2.1 United States Pyelonephritis Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pyelonephritis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Finafloxacin
  1.2.4 Fosfomycin Tromethamine
  1.2.5 Nacubactam
  1.2.6 Plazomicin Sulfate
  1.2.7 Others
1.3 United States Pyelonephritis Drug Market by Application/End Users
  1.3.1 United States Pyelonephritis Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Pyelonephritis Drug Market by Region
  1.4.1 United States Pyelonephritis Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pyelonephritis Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Pyelonephritis Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pyelonephritis Drug Status and Prospect (2012-2022)
  1.4.5 New England Pyelonephritis Drug Status and Prospect (2012-2022)
  1.4.6 The South Pyelonephritis Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Pyelonephritis Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pyelonephritis Drug (2012-2022)
  1.5.1 United States Pyelonephritis Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Pyelonephritis Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES PYELONEPHRITIS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pyelonephritis Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pyelonephritis Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pyelonephritis Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Pyelonephritis Drug Market Competitive Situation and Trends
  2.4.1 United States Pyelonephritis Drug Market Concentration Rate
  2.4.2 United States Pyelonephritis Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pyelonephritis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PYELONEPHRITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pyelonephritis Drug Sales and Market Share by Region (2012-2017)
3.2 United States Pyelonephritis Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Pyelonephritis Drug Price by Region (2012-2017)

4 UNITED STATES PYELONEPHRITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pyelonephritis Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pyelonephritis Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Pyelonephritis Drug Price by Type (2012-2017)
4.4 United States Pyelonephritis Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PYELONEPHRITIS DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pyelonephritis Drug Sales and Market Share by Application (2012-2017)
5.2 United States Pyelonephritis Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PYELONEPHRITIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Achaogen Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pyelonephritis Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Achaogen Inc Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca Plc
  6.2.2 Pyelonephritis Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Plc Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Meiji Seika Pharma Co Ltd
  6.3.2 Pyelonephritis Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co Inc
  6.4.2 Pyelonephritis Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co Inc Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 MerLion Pharmaceuticals Pte Ltd
  6.5.2 Pyelonephritis Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 The Medicines Company
  6.6.2 Pyelonephritis Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 The Medicines Company Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Zavante Therapeutics Inc
  6.7.2 Pyelonephritis Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Zavante Therapeutics Inc Pyelonephritis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 PYELONEPHRITIS DRUG MANUFACTURING COST ANALYSIS

7.1 Pyelonephritis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pyelonephritis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pyelonephritis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pyelonephritis Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PYELONEPHRITIS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pyelonephritis Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pyelonephritis Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Pyelonephritis Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Pyelonephritis Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pyelonephritis Drug
Figure United States Pyelonephritis Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Pyelonephritis Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Finafloxacin Product Picture
Figure Fosfomycin Tromethamine Product Picture
Figure Nacubactam Product Picture
Figure Plazomicin Sulfate Product Picture
Figure Others Product Picture
Figure United States Pyelonephritis Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Pyelonephritis Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Pyelonephritis Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pyelonephritis Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Pyelonephritis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pyelonephritis Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Pyelonephritis Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Pyelonephritis Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pyelonephritis Drug Sales Share by Players/Suppliers
Figure 2017 United States Pyelonephritis Drug Sales Share by Players/Suppliers
Figure United States Pyelonephritis Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pyelonephritis Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pyelonephritis Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pyelonephritis Drug Revenue Share by Players/Suppliers
Figure 2017 United States Pyelonephritis Drug Revenue Share by Players/Suppliers
Table United States Market Pyelonephritis Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Pyelonephritis Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Pyelonephritis Drug Market Share of Top 3 Players/Suppliers
Figure United States Pyelonephritis Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pyelonephritis Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pyelonephritis Drug Product Category
Table United States Pyelonephritis Drug Sales (K Pcs) by Region (2012-2017)
Table United States Pyelonephritis Drug Sales Share by Region (2012-2017)
Figure United States Pyelonephritis Drug Sales Share by Region (2012-2017)
Figure United States Pyelonephritis Drug Sales Market Share by Region in 2016
Table United States Pyelonephritis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pyelonephritis Drug Revenue Share by Region (2012-2017)
Figure United States Pyelonephritis Drug Revenue Market Share by Region (2012-2017)
Figure United States Pyelonephritis Drug Revenue Market Share by Region in 2016
Table United States Pyelonephritis Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Pyelonephritis Drug Sales (K Pcs) by Type (2012-2017)
Table United States Pyelonephritis Drug Sales Share by Type (2012-2017)
Figure United States Pyelonephritis Drug Sales Share by Type (2012-2017)
Figure United States Pyelonephritis Drug Sales Market Share by Type in 2016
Table United States Pyelonephritis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pyelonephritis Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pyelonephritis Drug by Type (2012-2017)
Figure Revenue Market Share of Pyelonephritis Drug by Type in 2016
Table United States Pyelonephritis Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Pyelonephritis Drug Sales Growth Rate by Type (2012-2017)
Table United States Pyelonephritis Drug Sales (K Pcs) by Application (2012-2017)
Table United States Pyelonephritis Drug Sales Market Share by Application (2012-2017)
Figure United States Pyelonephritis Drug Sales Market Share by Application (2012-2017)
Figure United States Pyelonephritis Drug Sales Market Share by Application in 2016
Table United States Pyelonephritis Drug Sales Growth Rate by Application (2012-2017)
Figure United States Pyelonephritis Drug Sales Growth Rate by Application (2012-2017)
Table Achaogen Inc Basic Information List
Table Achaogen Inc Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Achaogen Inc Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure Achaogen Inc Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure Achaogen Inc Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table Meiji Seika Pharma Co Ltd Basic Information List
Table Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure Meiji Seika Pharma Co Ltd Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table Merck & Co Inc Basic Information List
Table Merck & Co Inc Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co Inc Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure Merck & Co Inc Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure Merck & Co Inc Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table MerLion Pharmaceuticals Pte Ltd Basic Information List
Table MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table The Medicines Company Basic Information List
Table The Medicines Company Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure The Medicines Company Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure The Medicines Company Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure The Medicines Company Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table Zavante Therapeutics Inc Basic Information List
Table Zavante Therapeutics Inc Pyelonephritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zavante Therapeutics Inc Pyelonephritis Drug Sales Growth Rate (2012-2017)
Figure Zavante Therapeutics Inc Pyelonephritis Drug Sales Market Share in United States (2012-2017)
Figure Zavante Therapeutics Inc Pyelonephritis Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pyelonephritis Drug
Figure Manufacturing Process Analysis of Pyelonephritis Drug
Figure Pyelonephritis Drug Industrial Chain Analysis
Table Raw Materials Sources of Pyelonephritis Drug Major Players/Suppliers in 2016
Table Major Buyers of Pyelonephritis Drug
Table Distributors/Traders List
Figure United States Pyelonephritis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Pyelonephritis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pyelonephritis Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Pyelonephritis Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Pyelonephritis Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pyelonephritis Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pyelonephritis Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources